The Larivière & Massicotte Pharmacy receives an accreditation by an international organization
Why is this accreditation important to us?
In a context where specialized medications – particularly oncology and rare disease medicines – are often complex, our practice dedicated to oncology and rare disease care is constantly evolving. We opted for such rigorous accreditation process for various reasons:
• To further improve our services according to internationally recognized standards, such as those established by the ASCO (American Society of Clinical Oncology Patient-centered standards medically integrated dispensing) and NCODA
• To provide patients with a personalized, human, and safe support
• To improve our processes and our working organisation in order to collaborate more effectively with healthcare professionals and seek flowing continuous care.
The NCODA accreditation reflects many quality criteria involved in numerous aspects of our practice: healthcare management, safety, logistics, team training, patient support, interprofessional coordination, etc.
This accreditation reflects our commitment to maintain and elevate our quality services to patients, their caregivers, and healthcare providers.
It reaffirms our willingness to pursue our efforts in providing structured, collaborative, and human support during each step of the healthcare pathway.
Our vision
This international recognition is not an outcome, but a milestone in our commitment to a collaborative and patient-centered healthcare system.
We will continuously improve our practices and promote this model across Quebec, while remaining faithful to our core values: collaboration, expertise, and quality service.
📣 To learn more about the ‘‘NCODA Center of Excellence’’ Accreditation
Should you need further details regarding the standards developed by the American Society of Clinical Oncology (ASCO) and the Network for Collaborative Oncology Development & Advancement (NCODA), a non-profit international organization dedicated to promoting the improvement of integrated care and quality services to patients with cancer and/or receiving a complex therapy. here are some resources:
ASCO-NCODA standards for Medically Integrated Dispensing Pharmacy.
https://www.asco.org/practice-patients/cancer-care-standards/patient-centered-standards-medically-integrated-dispensing
Published online, May 27, 2025 DOI: 10.1200/OP.25.00279
📧 Do you have any questions? Please contact us: Contact
The patient is at the core of our mission
We proudly help our patients with the following:
Proactive and structured follow-up
Proactive and structured follow-up at each step of the therapy
Support in the administrative steps
Support to overcome administrative obstacles: approvals, access to medication, assessment of potential financial support
Pharmacist assessment adapted to each patient
Regular assessment of observance and side effects
Facilitated access to a dedicated clinical team
Facilitated access to a coordinated and available clinical team of pharmacists, in collaboration with the patient’s attending physician and various stakeholders.
Do you or a loved one plan to use our services regarding specialty medication?
Our team is here to assist you.